Lv3
220 积分 2025-01-17 加入
Prognostic Impact and Predictive Model for Early Non-curative Recurrence After Liver Resection for Hepatocellular Carcinoma: a Retrospective Cohort Study
5天前
已关闭
Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1
16天前
已完结
Abc-06: a Randomised Phase Iii, Multi-Centre, Open-Label Study of Active Symptom Control (Asc) Alone or Asc with Oxaliplatin / 5-Fu Chemotherapy for Patients with Locally Advanced / Metastatic Biliary Tract Cancers (Abc) Previously Treated with Cisplatin / Gemcitabine Chemotherapy
1个月前
已关闭
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
1个月前
已完结
CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study
1个月前
已完结
Case 9-2025: A 59-Year-Old Man with Hepatocellular Carcinoma
1个月前
已完结
Clinical efficacy and security analysis of DEB-TACE combined with trans arterial infusion of carrelizumab in the therapy of advanced liver cancer
2个月前
已关闭
Surgery Versus Ablation for Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF-RCT Trial) and a Nonrandomized Prospective Observational Trial (SURF-Cohort Trial)
2个月前
已完结
Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan
3个月前
已完结
Does immune checkpoint inhibitor exhibit limited efficacy against non‐viral hepatocellular carcinoma?: A review of clinical trials
3个月前
已完结
皖公网安备34019202002308
